预测格雷夫斯病复发风险：对“甲状腺过氧化物酶抗体阳性与格雷夫斯病抗甲状腺药物治疗后的无复发生存相关”的评论 - Suppr | 超能文献

Predicting the Risk of Graves Disease Relapse: Commentary on "Thyroid Peroxidase Antibody Positivity is Associated with Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease".

作者信息

Gallo D, Tanda M L, Piantanida E

机构信息

From the Department of Medicine and Surgery, Endocrine Unit, University of Insubria, Varese, Italy.

From the Department of Medicine and Surgery, Endocrine Unit, University of Insubria, Varese, Italy..

出版信息

Endocr Pract. 2020 Sep;26(9):1039-1041. doi: 10.4158/EP-2020-0230.

DOI:10.4158/EP-2020-0230

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Predicting the Risk of Graves Disease Relapse: Commentary on "Thyroid Peroxidase Antibody Positivity is Associated with Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease".预测格雷夫斯病复发风险：对“甲状腺过氧化物酶抗体阳性与格雷夫斯病抗甲状腺药物治疗后的无复发生存相关”的评论

Endocr Pract. 2020 Sep;26(9):1039-1041. doi: 10.4158/EP-2020-0230.

2

Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy.甲状腺过氧化物酶和甲状腺球蛋白抗体的变化可能与抗甲状腺药物治疗后 Graves 病的复发有关。

Endocrinol Metab (Seoul). 2019 Sep;34(3):268-274. doi: 10.3803/EnM.2019.34.3.268.

3

Thyroid Peroxidase Antibody Positivity is Associated With Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease.甲状腺过氧化物酶抗体阳性与Graves病抗甲状腺药物治疗后的无复发生存相关。

Endocr Pract. 2020 Sep;26(9):1026-1030. doi: 10.4158/EP-2020-0035.

4

Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.采用人促甲状腺激素受体的新型促甲状腺激素结合抑制活性测定法在抗甲状腺药物治疗的格雷夫斯病随访中的临床价值。与促甲状腺激素刺激抗体生物测定法的比较。

Clin Endocrinol (Oxf). 2001 Jan;54(1):89-96. doi: 10.1046/j.1365-2265.2001.01197.x.

5

Valuable predictive features of relapse of Graves' disease after antithyroid drug treatment.抗甲状腺药物治疗后Graves病复发的重要预测特征。

Ann Endocrinol (Paris). 2015 Dec;76(6):679-83. doi: 10.1016/j.ando.2015.08.004. Epub 2015 Oct 27.

6

The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.细胞毒性T淋巴细胞相关蛋白4（CTLA-4）基因、促甲状腺激素受体（TSHR）基因及调节性T细胞作为格雷夫斯病患者复发风险因素的作用

Acta Med Indones. 2017 Jul;49(3):195-204.

7

Thyroid-stimulating hormone receptor antibodies during follow-up as remission markers in childhood-onset Graves' disease treated with antithyroid drugs.随访中甲状腺刺激素受体抗体作为儿童发病格雷夫斯病抗甲状腺药物治疗缓解的标志物。

Kaohsiung J Med Sci. 2020 Apr;36(4):281-286. doi: 10.1002/kjm2.12167. Epub 2019 Dec 18.

8

Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.抗甲状腺药物可抑制放射性碘诱导的甲状腺功能亢进型格雷夫斯病患者甲状腺自身抗体升高。

Thyroid. 1999 Aug;9(8):775-9. doi: 10.1089/thy.1999.9.775.

9

Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs.甲巯咪唑剂量对格雷夫斯病缓解率有影响吗？一项长期前瞻性研究的结果。欧洲抗甲状腺药物治疗甲状腺功能亢进多中心试验组

Clin Endocrinol (Oxf). 1998 Oct;49(4):451-7. doi: 10.1046/j.1365-2265.1998.00554.x.

10

High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.在接受丙硫氧嘧啶治疗的儿童期发病的格雷夫斯病中抗中性粒细胞胞浆抗体阳性的高患病率。

J Clin Endocrinol Metab. 2000 Nov;85(11):4270-3. doi: 10.1210/jcem.85.11.7000.

引用本文的文献

1

[Expression of thyroglobulin antibody and thyroid peroxidase antibody in children with immune thrombocytopenia].[免疫性血小板减少症患儿甲状腺球蛋白抗体和甲状腺过氧化物酶抗体的表达]

Zhongguo Dang Dai Er Ke Za Zhi. 2022 Jun 15;24(6):687-692. doi: 10.7499/j.issn.1008-8830.2112150.